Madrigal Pharmaceuticals, Inc (MDGL) insider trading
Every open-market stock purchase and sale by Madrigal Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- William John Sibold (CEO) and 1 other sold $6.6M in the last 90 days.
- Last insider buy: Baker Bros. Advisors LP (Insider), $5.2M, 14 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $79.7M (28 sales). Last close $457.96 on Oct 21, 2026.
Recent MDGL insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 11, 2026 | William John Sibold (CEO) | Sold | $837K |
| Sep 11, 2026 | William John Sibold (CEO) | Sold | $652K |
| Sep 11, 2026 | William John Sibold (CEO) | Sold | $415K |
| Sep 11, 2026 | William John Sibold (CEO) | Sold | $371K |
| Sep 11, 2026 | William John Sibold (CEO) | Sold | $199K |
| Sep 11, 2026 | William John Sibold (CEO) | Sold | $117K |
| Sep 11, 2026 | William John Sibold (CEO) | Sold | $86K |
| Sep 11, 2026 | William John Sibold (CEO) | Sold | $65.6K |
| Sep 11, 2026 | William John Sibold (CEO) | Sold | $56.6K |
| Sep 11, 2026 | William John Sibold (CEO) | Sold | $32K |
| Sep 9, 2026 | William John Sibold (CEO) | Sold | $558K |
| Sep 9, 2026 | William John Sibold (CEO) | Sold | $345K |
| Sep 9, 2026 | William John Sibold (CEO) | Sold | $344K |
| Sep 9, 2026 | William John Sibold (CEO) | Sold | $280K |
| Sep 9, 2026 | William John Sibold (CEO) | Sold | $277K |
| Sep 9, 2026 | William John Sibold (CEO) | Sold | $273K |
| Sep 9, 2026 | William John Sibold (CEO) | Sold | $273K |
| Sep 9, 2026 | William John Sibold (CEO) | Sold | $212K |
| Sep 9, 2026 | William John Sibold (CEO) | Sold | $196K |
| Sep 9, 2026 | William John Sibold (CEO) | Sold | $196K |
| Sep 9, 2026 | William John Sibold (CEO) | Sold | $184K |
| Sep 9, 2026 | William John Sibold (CEO) | Sold | $116K |
| Sep 9, 2026 | William John Sibold (CEO) | Sold | $86.8K |
| Sep 9, 2026 | William John Sibold (CEO) | Sold | $69.2K |
| Aug 17, 2026 | Shannon T Kelley (General Counsel) | Sold | $342K |
Who's trading MDGL
- William John Sibold, CEO: sold $10.5M (37 sales), last Sep 11, 2026
- Shannon T Kelley, General Counsel: sold $842K (4 sales), last Aug 17, 2026
- John C Reed, Director: other filings, last Aug 15, 2026
- James M Daly, Director: other filings, last Jun 17, 2026
- Rebecca Taub, Director: sold $20.9M (38 sales), last Jun 17, 2026
- Jacqualyn A Fouse, Director: other filings, last Jun 17, 2026
- Baker Bros. Advisors LP, Director: other filings, last Jun 17, 2026
- Richard S Levy, Director: sold $7.3M (25 sales), last Jun 17, 2026
- Daniel J. Brennan, Director: other filings, last Jun 17, 2026
- David Soergel, C-suite exec: sold $952K (2 sales), last Jun 1, 2026
- Carole Huntsman, C-suite exec: sold $1.4M (9 sales), last Mar 6, 2026
- Mardi Dier, CFO: sold $3M (19 sales), last Mar 6, 2026
- Rita Thakkar, C-suite exec: other filings, last Jan 15, 2026
- Paul A Friedman, Director: sold $26.6M (37 sales), last Jan 9, 2026
- Kenneth Bate, Director: sold $8M (11 sales), last Nov 5, 2025
Get free alerts when an insider at Madrigal Pharmaceuticals, Inc files a new trade →